Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions

Immunity

Volumn 6, Issue 4, 1997, Pages 479-490

  Franzoso, Guido ^a   Carlson, Louise ^a   Scharton Kersten, Tanya ^b   Shores, Elizabeth W ^a   Epstein, Suzanne ^a   Grinberg, Alexander ^c   Tran, Tom ^a   Shacter, Emily ^a   Leonardi, Antonio ^a   Anver, Miriam ^d   Love, Paul ^c   Sher, Alan ^b   Siebenlist, Ulrich ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; GERMINAL CENTER; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 17144433112     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80291-5     Document Type: Article

References (69)

1. Ahearn, J.M., Fischer, M.B., Croix, D., Goerg, S., Ma, M., Xia, J., Zhou, X., Howard, R.G., Rothstein, T.L., and Carroll, M.C. (1996). Disruption of the Cr2 locus results in a reduction in B-1a cells and an impaired B cell response to T-dependent antigen. Immunity 4, 251-262.
2. Baeuerle, P.A., and Henkel, T. (1994). Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179.
3. Baldwin, A.S., Jr. (1996). The NF-κB and I-κB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-681.
4. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S., and Baltimore, D. (1995a). Embryonic lethality and liver degeneration in mice lacking the ReIA component of NF-κB. Nature 376, 167-170.
5. Beg, A.A., Sha, W.C., Bronson, R.T., and Baltimore, D. (1995b). Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes. Dev. 9, 2736-2746.
6. Biron, C.A., and Gazzinelli, R.T. (1995). Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr. Opin. Immunol. 7, 485-496.
7. Bours, V., Franzoso, G., Azarenko, V., Park, S., Kanno, T., Brown, K., and Siebenlist, U. (1993). The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72, 729-739.
8. Briskin, M.J., McEvoy, L.M., and Butcher, E.C. (1993). MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1. Nature 363, 461-464.
9. Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconi, L.A., Olson, D., Tizard, R., Cate, R., and Lo, D. (1995). Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373, 531-536.
10. Caamaño, J.H., Perez, P., Lira, S.A., and Bravo, R. (1996). Constitutive expression of Bcl-3 in thymocytes increases the DNA binding of NF-κB1 (p50) homodimers in vivo. Mol. Cell. Biol. 16, 1342-1348.
11. Campbell, K.A., Ovendale, P.J., Kennedy, M.K., Fanslow, W.C., Reed, S.G., and Maliszewski, C.R. (1996). CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4, 283-289.
12. Cao, X., Shores, E.W., Hu-Li, J., Anver, M.R., Kelsall, B.L., Russell, S.M., Drago, J., Noguchi, M., Grinberg, A., Bloom, E.T., Paul, W.E., Katz, S.I., Love, P.E., and Leonard, W.J. (1995). Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 2, 223-238.
13. Chang, C.-C., Zhang, J., Lombardi, L., Neri, A., and Dalla-Favera, R. (1995). Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators. Mol. Cell. Biol. 15, 5180-5187.
14. Cosgrove, D., Gray, D., Dierich, A., Kaufman, J., Lemeur, M., Benoist, C., and Mathis, D. (1991). Mice lacking MHC class II molecules. Cell 66, 1051-1066.
15. Coutelier, J.P., van der Logt, J.T., Heessen, F.W., Warnier, G., and Van Snick, J. (1987). IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 165, 64-69.
16. DeTogni, P., Goellner, J., Ruddle, N.H., Streeter, P.R., Fick, A., Mariathasan, S., Smith, S.C., Carlson, R., Shornick, L.P., and Schoenberger, J. (1994). Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264, 703-707.
17. Ettinger, R., Browning, J., Michie, S.A., Van Ewijk, W., and McDevitt, H.O. (1996). Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-β receptor-IgG1 fusion protein. Proc. Natl. Acad. Sci. USA 93, 13102-13107.
18. Ferguson, S.E., Han, S., Kelsoe, G., and Thompson, C.B. (1996). CD28 is required for germinal center formation. J. Immunol. 156, 4576-4581.
19. Franzoso, G., Bours, V., Park, S., Tomita-Yamaguchi, M., Kelly, K., and Siebenlist, U. (1992). The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature 359, 339-342.
20. Franzoso, G., Bours, V., Azarenko, V., Park, S., Tomita-Yamaguchi, M., Kanno, T., Brown, K., and Siebenlist, U. (1993). The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select κB sites. EMBO J. 12, 3893-3901.
21. Fujita, T., Nolan, G.P., Liou, H.-C., Scott, M.L., and Baltimore, D. (1993). The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev. 7, 1354-1363.
22. Gazzinelli, R.T., Denkers, E.Y., and Sher, A. (1993). Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites. Infect. Agents Dis. 2, 139-149.
23. Gerondakis, S., Strasser, A., Metcalf, D., Grigoriadis, G., Scheerlinck, J.Y., and Grumont, R.J. (1996). Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA 93, 3405-3409.
24. Grewal, I.S., Xu, J., and Flavell, R.A. (1995). Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378, 617-620.
25. Grouard, G., de Bouteiller, O., Barthelemy, C., Lebecque, S., Banchereau, J., and Liu, Y.J. (1995). Regulation of human B cell activation by follicular dendritic cell and T cell signals. Curr. Topics Microbiol. Immunol. 201, 105-117.
26. Hakim, F.T., Gazzinelli, R.T., Denkers, E., Hieny, S., Shearer, G.M., and Sher, A. (1991). CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J. Immunol. 147, 2310-2316.
27. Hatada, E.N., Nieters, N., Wulczyn, F.G., Naumann, M., Meyer, R., Nucifora, G., McKeithan, T.W., and Scheidereit, C. (1992). The ankyrin repeat domains of the NF-κB precursor p105 and the protooncogene bcl-3 act as specific inhibitiors of NF-κB DNA binding. Proc. Natl. Acad. Sci. USA 89, 2489-2493.
28. Hibbs, M.L., Tarlinton, D.M., Armes, J., Grail, D., Hodgson, G., Maglitto, R., Stacker, S.A., and Dunn, A.R. (1995). Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83, 301-311.
29. Hunter, C.A., Subauste, C.S., Van Cleave, V.H., and Remington, J.S. (1994). Production of γ interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor-α. Infect. Immun. 62, 2818-2824.
30. Inoue, J., Takahara, T., Akizawa, T., and Hino, O. (1993). Bcl-3, a member of the IκB proteins, has distinct specificity towards the Rel family of proteins. Oncogene 8, 2067-2073.
31. James, S.L. (1995). Role of nitric oxide in parasitic infections. Microbiol. Rev. 59, 533-547.
32. Kamanaka, M., Yu, P., Yasui, T., Yoshida, K., Kawabe, T., Horii, T., Kishimoto, T., and Kikutani, H. (1996). Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4, 275-281.
33. Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., and Kikutani, H. (1994). The immune response in CD40-deficient mice:impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167-178.
34. Kelsall, B.L., and Strober, W. (1996). Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J. Exp. Med. 183, 237-247.
35. Kelsoe, G. (1995). In situ studies of the germinal center reaction. Adv. Immunol. 60, 267-288.
36. Kim, U., Qin, X.-F., Gong, S., Stevens, S., Luo, Y., Nussenzweig, M., and Roeder, R.G. (1996). The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature 383, 542-547.
37. Klement, J.F., Rice, N.R., Car, B.D., Abbondanzo, S.J., Powers, G.D., Bhatt, P.H., Chen, C.H., Rosen, C.A., and Stewart, C.L. (1996). IκBα deficiency results in sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16, 2341-2349.
38. Kontgen, F., Grumont, R.J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D., and Gerondakis, S. (1995). Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9, 1965-1977.
39. Kosco-Vilbois, M.H., and Scheidegger, D. (1995). Folliculardendritic cells: antigen retention, B cell activation, and cytokine production. Curr. Topics Microbiol. Immunol. 201, 69-82.
40. Lane, P., Burdet, C., Hubele, S., Scheidegger, D., Muller, U., McConnell, F., and Kosco-Vilbois, M. (1994). B cell function in mice transgenic for mCTLA4-Hγ1: lack of germinal centers correlated with poor affinity maturation and class switching despite normal priming of CD4+ T cells. J. Exp. Med. 179, 819-830.
41. Leenen, P.J., de Bruijn, M.F., Voerman, J.S., Campbell, P.A., and van Ewijk, W. (1994). Markers of mouse macrophage development detected by monoclonal antibodies. J. Immunol. Meth. 174, 5-19.
42. LeHir, M., Bluethmann, H., Kosco-Vilbois, M.H., Muller, M., di Padova, F., Moore, M., Ryffel, B., and Eugster, H.P. (1996). Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J. Exp. Med. 183, 2367-2372.
43. Liu.Y.-J., and Banchereau, J. (1996). Mutant mice without B lymphocyte follicles. J. Exp. Med. 184, 1207-1211.
44. MacLennan, I.C.M. (1994). Germinal centers. Annu. Rev. Immunol. 12, 117-139.
45. Matsumoto, M., Lo, S.F., Carruthers, C.J., Min, J., Mariathasan, S., Huang, G., Plas, D.R., Martin, S.M., Geha, R.S., Nahm, M.H., and Chaplin, D.D. (1996a). Affinity maturation without germinal centres in lymphotoxin-α-deficient mice. Nature 382, 462-466.
46. Matsumoto, M., Mariathasan, S., Nahm, M.H., Baranyay, F., Peschon, JJ., and Chaplin, D.D. (1996b). Role of lymphotoxin and the type 1 TNF receptor in the formation of germinal centers. Science 271, 1289-1291.
47. Michaelson, J.S., Singh, M., Snapper, C.M., Sha, W.C., Baltimore, D., and Birshtein, B.K. (1996). Regulation of 3′ IgH enhancers by a common set of factors, including κB-binding proteins. J. Immunol. 156, 2828-2839.
48. Naumann, M., Wulczyn, F.G., and Scheidereit, C. (1993). The NF-κB precursor p105 and the proto-oncogene product Bcl-3 are IκB molecules and control nuclear translocation of NF-κB. EMBO J. 12, 213-222.
49. Nishizumi, H., Taniuchi, I., Yamanashi, Y., Kitamura, D., Ilic, D., Mori, S., Watanabe, T., and Yamamoto, T. (1995). Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyndeficient mice. Immunity 3, 549-560.
50. Nolan, G.P., Fujita, T., Bhatia, K., Huppi, K., Liou, H.-C., Scott, M.L., and Baltimore, D. (1993). The bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 in a phosphorylation-dependent manner. Mol. Cell. Biol. 13, 3557-3566.
51. Ohno, H., Takimoto, G., and McKeithan, T.W. (1990). The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60, 991-997.
52. Pasparakis, M., Alexopoulou, L., Episkopou, V., and Kollias, G. (1996). Immune and inflammatory responses in TNF-α-deficient mice: a critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184, 1397-1411.
53. Rickert, R.C., Rajewsky, K., and Roes, J. (1995). Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376, 352-355.
54. Scharton-Kersten, T.M., Wynn, T.A., Denkers, E.Y., Bala, S., Showe, L., Grunvald, E., Hieny, S., Gazzinelli, R.T., and Sher, A. (1996). In the absence of endogenous IFN-γ mice develop unimpaired IL-12 response to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157, 4045-4054.
55. Schubart, D.B., Rolink, A., Kosco-Vilbois, M.H., Botteri, F., and Matthias, P. (1996). B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature 383, 538-542.
56. Sha, W.C., Liou, H.C., Tuomanen, E.I., and Baltimore, D. (1995). Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80, 321-330.
57. Shores, E.W., Huang, K., Tran, T., Lee, E., Grinberg, A., and Love, P.E. (1994). Role of TCR ζ chain in T cell development and selection. Science 266, 1047-1050.
58. Siebenlist, U., Franzoso, G., and Brown, K. (1994). Structure, regulation and function of NF-κB. Annu. Rev. Cell. Biol. 10, 405-455.
59. Snapper, C.M., Zelazowski, P., Rosas, F.R., Kehry, M.R., Tian, M., Baltimore, D., and Sha, W.C. (1996). B cells from p50/NF-κB knock-out mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J Immunol 156, 183-191.
60. Soong, L., Xu, J.C., Grewal, I.S., Kima, P., Sun, J., Longley, B.J., Ruddle, N.H., McMahon-Pratt, D., and Flavell, R.A. (1996). Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4, 263-273.
61. Tew, J.G., Burton, G.F., Kupp, L.I., and Szakal, A. (1993). Follicular dendritic cells in germinal center reactions. Adv. Exp. Med. Biol. 329, 461-465.
62. Trinchieri, G. (1995). Interleukin-12: a proinflammatory cytokine with immunoregulatory function bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
63. Tybulewicz, V.L.J., Crawford, C.E., Jackson, P.K., Bronson, R.T., and Mulligan, R.C. (1991). Neonatal lethality and lymphopenia in mice with homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163.
64. Van Vliet, E., Melis, M., Foidart, J.M., and Van Ewijk, W. (1986). Reticular fibroblasts in peripheral lymphoid organs identified by a monoclonal antibody. J. Histochem. Cytochem. 34, 883-890.
65. Verma, I.M., Stevenson, J.K., Schwarz, E.M., Van Antwerp, D., and Miyamoto, S. (1995). Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9, 2723-2735.
66. Vieira, L.Q., Hondowicz, B.D., Afonso, L.C.C., Wysocka, M., Trinchieri, G., and Scott, P. (1994). Infection with Leishmania major involves interleukin-12 production in vivo. Immunol. Lett. 40, 157-161.
67. Weih, F., Carrasco, D., Durham, S.K., Barton, D.S., Rizzo, C.A., Ryseck, R.P., Lira, S.A., and Bravo, R. (1995). Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80, 331-340.
68. Wulczyn, F.G., Naumann, M., and Scheidereit, C. (1992). Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB. Nature 358, 597-599.
69. Xu, J., Foy, T.M., Laman, J.D., Elliott, E.A., Dunn, J.J., Waldschmidt, T.J., Elsemore, J., Noelle, R.J., and Flavell, R.A. (1994). Micedeficient for the CD40 ligand. Immunity 1, 423-431.